🔗 Permalink

Inventor profile of:

Andreas Muhs

City:

Pully

Country:

Switzerland

Published Applications:

31

Last publication date:

2017-05-18

Top Assignees for applications by Andreas Muhs

The entities that hold a legal rights for patent applications filed by inventor Muhs Andreas:

AC Immune S.A. 21 Lausanne, Switzerland
Genentech, Inc. 8 South San Francisco, CA United States
Katholieke Universiteit Leuven 5 Leuven, Belgium
ViaCord LLC 2 Waltham, MA United States
AC Immune S.A. 1 Lausanne, CH Switzerland
AC IMMUNE S.A. 1 , Switzerland
Genentech, Inc 1 San Francisco, CA United States
Genetech, Inc. 1 South San Francisco, CA United States
KATHOLIEKE UNIVERSITEIT LEUVEN 1 Waaistraat 6 - box 1015, Belgium

Recent patent applications by Muhs Andreas

Andreas Muhs from Pully, CH has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2017-05-18

US20170137502A1

Chemistry; metallurgy

Methods of diagnosing diseases caused by or associated with neurofibrillary tangles by phosphospecific antibodies recognising Tau

#2 | 2016-10-20

US20160304590A1

Chemistry; metallurgy

Methods of diagnosing tau-protein-associated disease

#3 | 2016-06-09

US20160158242A1

Human necessities

Compounds for the treatment of diseases associated with amyloid or amyloid-like proteins

#4 | 2014-10-02

US20140294731A1

Chemistry; metallurgy

Phosphospecific antibodies recognising tau

#5 | 2014-03-20

US20140079673A1

Human necessities

TREATMENT OF ISCHEMIA USING STEM CELLS

#6 | 2013-06-27

US20130164278A1

Chemistry; metallurgy

HUMANIZED ANTIBODY

#7 | 2012-12-27

US20120329149A1

Human necessities

Nucleic acid molecules encoding a humanized antibody

#8 | 2012-12-06

US20120309791A1

Chemistry; metallurgy

Compounds for the treatment of diseases associated with amyloid or amyloid-like proteins

#9 | 2012-11-15

US20120288896A1

Chemistry; metallurgy

NUCLEIC ACID MOLECULES ENCODING ANTI-AMYLOID-BETA ANTIBODIES

#10 | 2012-11-01

US20120276009A1

Chemistry; metallurgy

Pharmaceutical composition

#11 | 2012-09-27

US20120244165A1

Chemistry; metallurgy

METHODS OF TREATING AMYLOIDOSIS COMPRISING THE USE OF ANTI-AMYLOID BETA ANTIBODIES

#12 | 2012-07-19

US20120183599A1

Chemistry; metallurgy

Pharmaceutical composition of an antigenic tau peptide reconstituted in a liposome and related antibodies and cell lines

#13 | 2012-07-05

US20120171216A1

Polynucleotides encoding an anti-beta-amyloid monoclonal antibody

#14 | 2012-03-15

US20120064065A1

Chemistry; metallurgy

Methods for identifying safe and functional humanized antibodies

#15 | 2011-03-24

US20110070613A1

Chemistry; metallurgy

Monoclonal Antibody

#16 | 2010-11-25

US20100297132A1

Chemistry; metallurgy

Monoclonal antibody

#17 | 2010-11-25

US20100297013A1

Chemistry; metallurgy

HUMANIZED ANTIBODY

#18 | 2010-11-25

US20100297012A1

Chemistry; metallurgy

HUMANIZED ANTIBODY

#19 | 2010-11-18

US20100291097A1

Chemistry; metallurgy

Methods of treating ocular disease associated with amyloid-beta-related pathology using an anti-amyloid-beta antibody

#20 | 2010-09-30

US20100247688A1

Chemistry; metallurgy

PIRENZEPINE AND DERIVATIVES THEREOF AS ANTI-AMYLOID AGENTS

#21 | 2010-07-22

US20100183513A1

Chemistry; metallurgy

N-(METHYL) -1H-PYRAZOL-3-AMINE, N-(METHYL)-PYRIDIN-2-AMINE AND N-(METHYL)-THIAZOL-2-AMINE DERIVATIVES FOR THE TREATMENT OF DISEASES ASSOCIATED WITH AMYLOID OR AMYLOID-LIKE PROTEINS, LIKE E.G. ALZHEIMER'S

#22 | 2010-06-17

US20100150906A1

Human necessities

Methods of treating and monitoring disease with antibodies

#23 | 2010-06-10

US20100144793A1

Chemistry; metallurgy

NOVEL COMPOUNDS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH AMYLOID OR AMYLOID-LIKE PROTEINS

#24 | 2010-04-22

US20100098707A2

Chemistry; metallurgy

Monoclonal antibodies that recognize epitopes of amyloid-beta

#25 | 2010-04-01

US20100080800A1

Human necessities

Methods of treating amyloidosis with humanized anti-beta-amyloid antibodies

#26 | 2009-08-27

US20090214481A1

Human necessities

Treatment of ischemia using stem cells

#27 | 2009-06-18

US20090155249A1

Chemistry; metallurgy

HUMANIZED ANTIBODY IGG1

#28 | 2009-04-09

US20090093002A1

Human necessities

Humanized anti-beta-amyloid antibody

#29 | 2009-01-15

US20090017041A1

Monoclonal antibody

#30 | 2009-01-15

US20090017040A1

Human necessities

Monoclonal antibody

#31 | 2007-07-19

US20070166311A1

Chemistry; metallurgy

Monoclonal antibody

InventorID:

311402 ⎘